Thames AD, Becker BW, Marcotte TD, Hines LJ, Foley JM, Ramezani A, et al. Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance. Clin Neuropsychol. 2011;25(2):224–43.

Article  PubMed  PubMed Central  Google Scholar 

Knippels HM, Goodkin K, Weiss JJ, Wilkie FL, Antoni MH. The importance of cognitive self-report in early HIV-1 infection: validation of a cognitive functional status subscale. AIDS. 2002;16(2):259–67.

Article  PubMed  Google Scholar 

Yoo-Jeong M, Anderson A, Rahman AF, Baumann M, McBroom J, Waldrop-Valverde, D. Associations of mood on objective and subjective cognitive complaints in persons living with HIV/AIDS. J HIV/AIDS. 2018;4(1).https://doi.org/10.16966/2380-5536.146.

Nakao A, Yamanouchi J, Takenaka K, Takada K. The Iowa Gambling Task on HIV-infected subjects. J Infect Chemother. 2020;26(3):240–4.

Article  PubMed  Google Scholar 

Hinkin CH, Castellon SA, Hardy DJ, Granholm E, Siegle G. Computerized and traditional stroop task dysfunction in HIV-1 infection. Neuropsychology. 1999;13(2):306–16.

Article  CAS  PubMed  Google Scholar 

Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Lam MN, Stefaniak M, et al. Verbal and spatial working memory performance among HIV-infected adults. J Int Neuropsychol Soc. 2002;8(4):532–8.

Article  PubMed  Google Scholar 

Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16.

Article  CAS  PubMed  Google Scholar 

Wang Y, Liu M, Lu Q, Farrell M, Lappin JM, Shi J, et al. Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis. Neurology. 2020;95(19):e2610–21.

Article  CAS  PubMed  Google Scholar 

Wei J, Hou J, Su B, Jiang T, Guo C, Wang W, et al. The prevalence of Frascati-criteria-based HIV-associated neurocognitive disorder (HAND) in HIV-infected adults: a systematic review and meta-analysis. Front Neurol. 2020;11:581346.

Article  PubMed  PubMed Central  Google Scholar 

Korten V, Ay U, Hari E, Tigen Tukenmez E, Gencer S, Akca Kalem S, et al. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke’s Cognitive Examination Revised (ACE-R) test as a screening tool. HIV Med. 2021;22(1):60–6.

Article  CAS  PubMed  Google Scholar 

Flatt A, Gentry T, Kellett-Wright J, Eaton P, Joseph M, Urasa S, et al. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged >/=50 years attending standard HIV clinical care in Kilimanjaro Tanzania. Int Psychogeriatr. 2023;35(7):339–50.

Article  PubMed  Google Scholar 

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99.

Article  CAS  PubMed  Google Scholar 

• Dastgheyb RM, Sacktor N, Franklin D, Letendre S, Marcotte T, Heaton R, et al. Cognitive trajectory phenotypes in human immunodeficiency virus-infected patients. J Acquir Immune Defic Syndr. 2019;82(1):61–70 (This work showed that a specific cognitive impairment profile (deficits in executive function, learning, and processing-speed) was less likely in cannabis-using versus cannabis-abstinent PWH. However, other impairment profiles incorporating these domains (e.g., the learning and memory profile) were not associated with CU. These data highlight the necessity of testing discrete cognitive domain functions in PWH, and the importance of interpreting global cognition scores with caution).

Rubin LH, Saylor D, Nakigozi G, Nakasujja N, Robertson K, Kisakye A, et al. Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai Uganda. J Neurovirol. 2019;25(6):800–13.

Article  PubMed  PubMed Central  Google Scholar 

Dastgheyb RM, Buchholz AS, Fitzgerald KC, Xu Y, Williams DW, Springer G, et al. Patterns and predictors of cognitive function among virally suppressed women with HIV. Front Neurol. 2021;12:604984.

Article  PubMed  PubMed Central  Google Scholar 

Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004;10(1):1–14.

Article  CAS  PubMed  Google Scholar 

Rothlind JC, Greenfield TM, Bruce AV, Meyerhoff DJ, Flenniken DL, Lindgren JA, et al. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int Neuropsychol Soc. 2005;11(1):70–83.

Article  PubMed  PubMed Central  Google Scholar 

Sassoon SA, Fama R, Rosenbloom MJ, O’Reilly A, Pfefferbaum A, Sullivan EV. Component cognitive and motor processes of the digit symbol test: differential deficits in alcoholism, HIV infection, and their comorbidity. Alcohol Clin Exp Res. 2007;31(8):1315–24.

Article  PubMed  Google Scholar 

Schulte T, Mueller-Oehring EM, Rosenbloom MJ, Pfefferbaum A, Sullivan EV. Differential effect of HIV infection and alcoholism on conflict processing, attentional allocation, and perceptual load: evidence from a Stroop Match-to-Sample task. Biol Psychiatry. 2005;57(1):67–75.

Article  PubMed  Google Scholar 

Rodriguez Salgado D, Rodriguez Alvarez M, Seoane PG. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users. Cogn Behav Neurol. 2006;19(2):95–104.

Article  CAS  PubMed  Google Scholar 

Wakim KM, Freedman EG, Molloy CJ, Vieyto N, Cao Z, Foxe JJ. Assessing combinatorial effects of HIV infection and former cocaine dependence on cognitive control processes: a high-density electrical mapping study of response inhibition. Neuropharmacology. 2021;195:108636.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wakim KM, Freedman EG, Tivarus ME, Heinecke A, Foxe JJ. Assessing combinatorial effects of HIV infection and former cocaine dependence on cognitive control processes: a functional neuroimaging study of response inhibition. Neuropharmacology. 2022;203:108815.

Article  CAS  PubMed  Google Scholar 

Kumar P, Mahato DK, Kamle M, Borah R, Sharma B, Pandhi S, et al. Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: an overview. Phytother Res. 2021;35(11):6010–29.

Article  CAS  PubMed  Google Scholar 

Shiau S, Arpadi SM, Yin MT, Martins SS. Patterns of drug use and HIV infection among adults in a nationally representative sample. Addict Behav. 2017;68:39–44.

Article  PubMed  PubMed Central  Google Scholar 

Costiniuk CT, Saneei Z, Salahuddin S, Cox J, Routy JP, Rueda S, et al. Cannabis consumption in people living with HIV: reasons for use, secondary effects, and opportunities for health education. Cannabis Cannabinoid Res. 2019;4(3):204–13.

Article  PubMed  PubMed Central  Google Scholar 

Harris GE, Dupuis L, Mugford GJ, Johnston L, Haase D, Page G, et al. Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada. Can J Infect Dis Med Microbiol. 2014;25(1):e1-7.

Article  PubMed  PubMed Central  Google Scholar 

Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol. 2013;64:21–47.

Article  PubMed  Google Scholar 

Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev. 2009;89(1):309–80.

Article  CAS  PubMed  Google Scholar 

Mackie K. Cannabinoid receptors: where they are and what they do. J Neuroendocrinol. 2008;20(Suppl 1):10–4.

Article  CAS  PubMed  Google Scholar 

Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia. 2010;58(9):1017–30.

Article  PubMed  PubMed Central  Google Scholar 

Zanettini C, Panlilio LV, Alicki M, Goldberg SR, Haller J, Yasar S. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci. 2011;5:57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu C, Hermes DJ, Nwanguma B, Jacobs IR, Mackie K, Mukhopadhyay S, et al. Endocannabinoids exert CB(1) receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein. Mol Cell Neurosci. 2017;83:92–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science. 2003;302(5642):84–8.

Article  CAS  PubMed  Google Scholar 

Ehrhart J, Obregon D, Mori T, Hou H, Sun N, Bai Y, et al. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation. 2005;2:29.

Article  PubMed  PubMed Central  Google Scholar 

Murray CH, Javanbakht M, Cho GD, Gorbach PM, Fulcher JA, Cooper ZD. Changes in immune-related biomarkers and endocannabinoids as a function of frequency of cannabis use in people living with and without HIV. Cannabis and cannabinoid research. Advance online publication. 2023. https://doi.org/10.1089/can.2022.0287.

Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199–215.

Article  CAS  PubMed  Google Scholar 

Wise LE, Thorpe AJ, Lichtman AH. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. Neuropsychopharmacology. 2009;34(9):2072–80.

Article  CAS  PubMed  Google Scholar